Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb (S-1874-69)
Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1,WARTS protein kinase (h-warts),WARTS,Serine/threonine-protein kinase LATS2,Kinase phosphorylated during mitosis protein,Large tumor suppressor homolog 2,Serine/threonine-protein kinase kpm,Warts-like kinase,KPM
产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
Phospho-LATS1/2(Ser909/872)分子别名
Serine/threonine-protein kinase LATS1; Large tumor suppressor homolog 1; WARTS protein kinase (h-warts); WARTS; Serine/threonine-protein kinase LATS2; Kinase phosphorylated during mitosis protein; Large tumor suppressor homolog 2; Serine/threonine-protein kinase kpm; Warts-like kinase; KPM免疫原
Synthetic Peptide细胞定位
Endoplasmic reticulumAccession
O95835, Q9NRM7克隆号
S-1874-69抗体类型
Recombinant mAb抗体同种型
IgG翻译后修饰类型
磷酸化反应种属 ?
Hu, Ms阳性样本
HeLa treated with 100 ng/ml Calyculin A for 30 minutes, serum-starved NIH/3T3 treated with 100 nM Calyculin A for 30 minutes纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
ICC ?
WB
稀释度
应用 稀释度 推荐种属 Dot Blot 1:1000 WB 1:1000 Hu, Ms ICC 1:500 Hu
Phospho-LATS1/2(Ser909/872) refers to the phosphorylated forms of the mammalian Hippo signaling pathway kinases LATS1 (Large Tumor Suppressor 1) and LATS2 at specific serine residues (Ser909 in LATS1 and Ser872 in LATS2). As core components of this pathway, LATS1/2 are activated through phosphorylation by upstream kinases MST1/2, which subsequently phosphorylate downstream effector proteins YAP/TAZ to regulate their nucleocytoplasmic shuttling, degradation, and biological functions, thereby suppressing cell proliferation and promoting apoptosis. Phosphorylation at Ser909/872 is likely a critical step in LATS1/2 activation, potentially modulating their kinase activity, stability, or interactions with regulatory proteins. This phosphorylation event is commonly used as a biomarker of Hippo pathway activity, detectable via specific antibodies (e.g., in Western blotting), and is studied in contexts such as cancer and organ development due to the pathway's strong association with tumorigenesis and metastasis. Notably, species-specific variations or splice isoforms may alter residue numbering, and functional validation often involves mutagenesis experiments (e.g., phosphomimetic glutamic acid substitutions or non-phosphorylatable alanine mutations) to assess impacts on pathway regulation.
免疫印迹
WB result of Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb
Primary antibody: Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated HeLa whole cell lysate 20 µg
Lane 2: HeLa treated with 100 ng/ml Calyculin A for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 127, 120 kDa
Observed MW: 140, 120 kDaWB result of Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb
Primary antibody: Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated NIH/3T3 whole cell lysate 20 µg
Lane 2: serum-starved NIH/3T3 treated with 100 nM Calyculin A for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 127, 120 kDa
Observed MW: 130, 115 kDa
斑点杂交
Dot blot result of Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb
Lane 1: LATS1/2(Ser909/872) phospho peptide
Lane 2: LATS1/2(Ser909/872) unmodified peptide
Primary antibody: Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb at 1/1000 dilution
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
免疫细胞化学
ICC analysis of HeLa cells treated with 100 ng/ml Calyculin A for 30 minutes (top panel) and untreated HeLa cells (below panel). Anti- Phospho-LATS1/2(Ser909/872) antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定
我们推荐客户使用TPST+5%脱脂奶粉来稀释一抗,进行封闭。 虽然BSA被推荐为WB检测磷酸化蛋白的常用封闭剂,但是脱脂奶粉获取更加方便,覆盖更广泛的非特异性结合位点,在一抗性能优越的前提下,使用脱脂奶粉封闭性价比更高







评论(0)